GSK Seeks Ax Of Zofran Birth Defect Claims

By Emily Field · June 11, 2019, 4:57 PM EDT

GlaxoSmithKline on Tuesday asked a Massachusetts federal judge to toss certain claims in multidistrict litigation alleging that its anti-nausea drug Zofran caused birth defects, saying that the patients hadn't shown the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Zofran (Ondansetron)Products Liability Litigation

Case Number

1:15-md-02657

Court

Massachusetts

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

October 13, 2015